期刊文献+

乳腺癌HER2检测的现状及存在的问题 被引量:15

暂未订购
导出
摘要 国内专家组于2009年12月编写发表的《乳腺癌HER2检测指南》标志着我国HER2检测向标准化方向迈上新的台阶,然而HER2检测仍存在许多争论和需要解决的问题。本文针对HER2检测方法的选择、相关的组织处理和固定、免疫组化抗体的比较、检测结果的判读、17号染色体多体以及免疫组化(immunohistochemistry,IHC)""病例的研究等内容做一综述。
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2010年第5期602-605,共4页 Chinese Journal of Clinical and Experimental Pathology
  • 相关文献

参考文献27

  • 1Wolff A C,Hammond M E,Schwartz J N,et al.American society of clinical oncology/college of american pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer[J].Arch Pathol Lab Med,2007,131(1):18-43.
  • 2乳腺癌HER2检测指南(2009版)[J].中华病理学杂志,2009,38(12):836-840. 被引量:194
  • 3唐涛.乳腺癌脑转移的相关因素研究进展[J].临床与实验病理学杂志,2008,24(1):96-98. 被引量:3
  • 4Yaziji H,Gown A M.Accuraccy and Precision in HER2 testing in HER2/neu testing in breast cancer:Are we there yet?[J].Hum Pathol,2004,35(2):143-6.
  • 5Sauter G,Lee J,Bartlett J M,et al.Guidelines for human epidermal growth factor receptor 2 testing:biologic and methodologic considerations[J].J Clin Oncol,2009,27(8):1323-33.
  • 6O'Malley F P,Thomson T,Julian J,et al.HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumab[J].Arch Pathol Lab Med,2008,132(1):61-5.
  • 7Bohn O L,Navarro L,Ayaquica C,et al.HER2 2+ breast cancer in Mexico,central America and the caribbean:re-testing results by a central lab(Meeting abstract)[J].Mod Pathol,2009,22(S1):31A.
  • 8Willmore-Payne C,Metzger K,Layfield L J.Effects of fixative and fixation protocols on assessment of Her-2/neu oncogene amplification status by fluorescence in situ hybridization[J].Appl Immunohistochem Mol Morphol,2007,15(1):84-7.
  • 9Dowsett M,Hanna W M,Kockx M,et al.Standardization of HER2 testing:results of an international proficiency-testing ring study[J].Mod Pathol,2007,20(5):584-91.
  • 10Bartlett J M,Ibrahim M,Jasani B,et al.External quality assurance of HER2 fluorescence in situ hybridisation testing:results of a UK NEQAS pilot scheme[J].J Clin Pathol,2007,60(7):816-9.

二级参考文献32

  • 1EvansAJ JamesJJ CornfordEJ ChanSY BurrellHC PinderSE GutteridgeE RobertsonJF HornbuckleJ CheungKL.Brain metastases from breast cancer: identification of a high-risk group[J].中国神经肿瘤杂志,2004,2(3):165-165. 被引量:16
  • 2吴强.c-erbB-2(HER-2/neu)与乳腺癌[J].临床与实验病理学杂志,2005,21(1):6-9. 被引量:16
  • 3杨举伦,史爱学,邹红,李涛,杨海捷,蔡琳.乳腺癌发生过程中p53、BRCA1、BRCA2、PTEN、Rb蛋白异常表达[J].临床与实验病理学杂志,2005,21(3):277-281. 被引量:9
  • 4<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:167
  • 5王跃华,王全红,李丽,肖彦增,殷卫东,杨宣琴,王丽霞,王晋芬.乳腺癌Her-2基因检测方法对比[J].临床与实验病理学杂志,2007,23(2):225-226. 被引量:11
  • 6Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol, 2007,25 ( 33 ) : 5287-5312.
  • 7Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol,2007,25( 1 ) :118-145.
  • 8Hanna WM, Kwok K. Chromogenic in-situ hybridization: a viable alternative to fluorescence in-situ hybridization in the HER2 testing algorithm. Mod Pathol,2006,19(4) :481-487.
  • 9Gong Y, Sweet W, Duh YJ, et al. Chromogenic in situ hybridization is a reliable method for detecting HER2 gene status in breast cancer: a multicenter study using conventional scoring criteria and the new ASCO/CAP recommendations. Am J Clin Pathol,2009,131 (4) :490-497.
  • 10Dietel M, Ellis IO, Hofler H, et al. Comparison of automated silver enhanced in situ hybridisation (SISH) and fluorescence ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of American Pathologists. Virchows Arch ,2007,451 ( 1 ) : 19-25.

共引文献203

同被引文献194

引证文献15

二级引证文献163

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部